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Abstract
Background: We previously described the first respiratory Saccharomyces cerevisiae strain, KOY.TM6*P, by
integrating the gene encoding a chimeric hexose transporter, Tm6*, into the genome of an hxt null yeast.
Subsequently we transferred this respiratory phenotype in the presence of up to 50 g/L glucose to a yeast strain,
V5 hxt1-7Δ, in which only HXT1-7 had been deleted. In this study, we compared the transcriptome of the resultant
strain, V5.TM6*P, with that of its wild-type parent, V5, at different glucose concentrations.
Results: cDNA array analyses revealed that alterations in gene expression that occur when transitioning from a
respiro-fermentative (V5) to a respiratory (V5.TM6*P) strain, are very similar to those in cells undergoing a
diauxic shift. We also undertook an analysis of transcription factor binding sites in our dataset by examining
previously-published biological data for Hap4 (in complex with Hap2, 3, 5), Cat8 and Mig1, and used this in
combination with verified binding consensus sequences to identify genes likely to be regulated by one or more of
these. Of the induced genes in our dataset, 77% had binding sites for the Hap complex, with 72% having at least
two. In addition, 13% were found to have a binding site for Cat8 and 21% had a binding site for Mig1.
Unexpectedly, both the up- and down-regulation of many of the genes in our dataset had a clear glucose
dependence in the parent V5 strain that was not present in V5.TM6*P. This indicates that the relief of glucose
repression is already operable at much higher glucose concentrations than is widely accepted and suggests that
glucose sensing might occur inside the cell.
Conclusion: Our dataset gives a remarkably complete view of the involvement of genes in the TCA cycle,
glyoxylate cycle and respiratory chain in the expression of the phenotype of V5.TM6*P. Furthermore, 88% of the
transcriptional response of the induced genes in our dataset can be related to the potential activities of just three
proteins: Hap4, Cat8 and Mig1. Overall, our data support genetic remodelling in V5.TM6*P consistent with a
respiratory metabolism which is insensitive to external glucose concentrations.
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We engineered the first respiratory Saccharomyces cerevisiae
strain, KOY.TM6*P, by integrating the gene encoding a
chimeric hexose transporter, Tm6*, into the genome of an
hxt null yeast [1]. Subsequently we demonstrated the
transferability of this respiratory phenotype to a yeast
strain, V5 hxt1-7Δ, in which only HXT1-7 had been
deleted [2]. The resulting V5.TM6*P strain produced only
minor amounts of ethanol when cultured on external glu-
cose concentrations as high as 5% [2]. Despite the fact that
the glucose flux was reduced to 30% in the V5.TM6*P
strain compared with that of its parental V5 strain, the
V5.TM6*P strain produced biomass at a specific rate as
high as 85% of that produced by the V5 wild-type strain,
the yield itself increasing by 50% in the mutant compared
to its parental strain.
Having performed this initial physiological characteriza-
tion of the V5.TM6*P strain, we wanted to examine more
thoroughly the basis of its respiratory phenotype by com-
paring its transcriptome with that of its wild-type parent
strain, V5. This approach has been widely used to obtain
a global picture of the cellular responses of yeast to a wide
range of physiological changes, including those experi-
enced at the diauxic shift [3-5]. Recently Ohlmeier and
colleagues [6] demonstrated that major changes at the
transcriptional level are not reflected at the protein level.
Indeed, focusing on the mitochondrial proteome follow-
ing a diauxic shift, they showed that the levels of only 18
out of 253 identified proteins had changed (17 increased,
and 1 decreased). Among them were proteins involved in
the tricarboxylic acid (TCA) cycle (Sdh1, Sdh2, and Sdh4)
and the respiratory chain (Cox4, Cyb2, and Qcr7). This
seeming disagreement with their observations of hetero-
geneous changes in the transcriptome (where more than
4,000 changes were recorded) is also consistent with our
own prior data where we showed that the protein patterns
obtained from a 2D-PAGE analysis of the two strains
(grown under the same conditions used in this study)
were not substantially different [2]. We did note, however,
that the levels of the upper-part glycolytic intermediates
and ATP did differ between the two strains, and that
Cdc19 is present in lower amounts in V5.TM6*P. This dis-
crepancy between proteome and transcriptome regulation
has also been observed by others [7] and is also consistent
with the fact that there is an acknowledged lack of rela-
tionship between the levels of glycolytic proteins and the
glycolytic flux [8-10]. Nonetheless, researchers continue
to depend on mRNA as an indicator of cellular state,
which is a situation that will continue while methods for
the global analysis of protein expression are improved [7].
In this respect, Brauer and colleagues [3-5] have used tran-
scriptome analysis to examine adjustments and remodel-
ling of the metabolism of glucose-limited yeast cultures.
In that study, the authors constructed metabolic models
consistent with their cDNA array data. In this work, the
V5.TM6*P strain was therefore characterized at the tran-
scriptome level in comparison with the parental V5 strain
in order to obtain a more global understanding of any
genetic remodelling underlying the physiological differ-
ences between them. Both strains were cultured in 50 g/L
glucose with six samples being taken at defined points
between 38 and 6 g/L glucose for cDNA array analysis in
two independent fermentations for each strain. Conse-
quently, we generated a highly redundant dataset (n = 12)
where 922 genes were either induced or repressed when
comparing V5 and V5.TM6*P under all glucose concentra-
tions. Using in vivo studies together with documented
binding specificities of three transcription factors known
to have a role in the regulation of respiratory genes (the
Hap complex, Cat8 and Mig1), it was possible to correlate
the up-regulation of all but 18 of the 146 genes induced
by a factor ≥2.0 with the presence of one or more of their
binding sites. This means that 75% of the transcriptional
response of the genes in our dataset could be related to the
activities of just three transcription factors, which in turn
would account for 88% of the response of the induced set.
Finally, we made the unexpected observation that both
the induction and repression of many of the genes in our
dataset had a clear glucose dependence in the parent V5
strain that was not present in V5.TM6*P. This important
result indicates that the relief of glucose repression in the
wild-type is already operable at much higher glucose con-
centrations than is currently widely accepted and that the
phenotype of the respiratory strain is glucose insensitive
by comparison.
Results
We compared the transcriptional profiles of the V5 and
V5.TM6*P strains cultured in 50 g/L glucose, with samples
extracted between 38 and 6 g/L residual glucose. We iden-
tified 190 genes with adjusted p-values < 0.05 that
changed their expression levels either up by a factor of
≥2.0 (146 genes) or down by a factor of ≤0.5 (44 genes)
when comparing the two strains at all three sampling
points. These genes are presented by functional category
of their gene products in Additional file 1 and are dis-
cussed below. Additional file 2 provides the information
in Excel format and also includes other relevant literature
data. A further 636 genes changed their expression levels
either up by a factor of <2.0 (317 genes) or down by a fac-
tor > 0.5 (319 genes) and are presented as part of Addi-
tional file 3. The remaining 96 genes were either dubious,
Ty-transposable elements, or were detected due to cross-
hybridisation, as indicated in the legend to Additional file
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V5.TM6*P compared with its parental strain also have an 
altered expression following diauxic shift
We compared our dataset with three sets of expression
data for yeast undergoing a diauxic shift, where the sam-
ples had been taken at least 2 hours after the glucose is
depleted [3-5]. Of the 190 genes in our dataset that
changed their expression levels either up or down by a fac-
tor of 2 or more, 154 of these could be identified as chang-
ing in the same direction in at least one of these three
datasets, with 124 having at least two matches. Only 8
genes (ERG3, RPS27A, YHB1, TRX1, YER188w, YKL066w,
YAR068w and Y0L150c) had changes that were in the
opposite direction in at least two of the datasets. This sig-
nificant overlap between our data set and the data sets of
the three previous studies is entirely consistent with the
fact that there is a transition from a respiro-fermentative
metabolism in V5 to a respiratory metabolism in
V5.TM6*P.
Glycolytic and gluconeogenic genes have substantially 
altered expression levels in V5.TM6*P
Four of the most strongly induced genes in Additional file
1 are the glycolytic genes, HXK1 (factor 9.0) and GLK1
(3.8), and the gluconeogenic genes, PCK1 (6.9) and FBP1
(5.3). Indeed, as shown in Figure 1, the induction in
V5.TM6*P of several glycolytic and gluconeogenic genes
could be consistent with these cells accommodating for a
lack of glucose; the hypothesized mechanism behind the
strain's reduced ethanol-producing, respiratory pheno-
type. The final step in glycolysis which produces pyruvate,
is catalyzed by pyruvate kinase. In V5.TM6*P the pyruvate
kinase genes, CDC19 and PYK2, respond in an opposing
manner: CDC19 is repressed by a factor of 0.4 (consistent
with our earlier proteome analysis where Cdc19 is present
in lower amounts in V5.TM6*P than V5) while PYK2 is
induced and is relieved of its glucose-repressed state as a
result of the low glucose flux in the respiratory strain.
Reduced ethanol production in V5.TM6*P compared to
the parental strain is also consistent with the two most
strongly repressed genes PDC1 (0.2) and PDC5 (0.2)
encoding the main pyruvate decarboxylases.
Alternative carbon source usage genes are induced in 
V5.TM6*P compared with V5, consistent with a reduced 
glucose flux
An adaptation to enable growth on alternative carbon
sources is seen in the induction of the plasma membrane
transporter genes MAL31 and STL1 as well as the genes
SUC2, GUT1, GUT2, ALD6 and BDH1 encoding proteins
for the utilization of sucrose, glycerol, acetaldehyde and
butanediol, respectively. GUT1 in particular is strongly
induced by a factor of 6.2, and STL1 is the most strongly
induced of all genes on the cDNA array (21.7), suggesting
that V5.TM6* has undergone a substantial genetic adjust-
ment compared to its parent. Furthermore, CYB2 (10.1)
and DLD3 (0.5), whose gene products are involved in the
conversion of lactate to pyruvate, and in the case of CYB2
feeding the released electrons into the electron transport
chain, are oppositely regulated. Biochemical data and
sequence patterns for YGL157w (0.3) [11], YAL061w (2.9)
and DSF1 (9.4, homologous to D-mannitol 2-dehydroge-
nase from Rhodobacter sphaeroides) suggest that these ORFs
encode an oxidoreductase, a polyol dehydrogenase and a
putative sugar dehydrogenase, respectively, which could
be involved in channelling alternative carbon sources into
the TCA cycle. The carbon-deficient state of V5.TM6*P [1]
could also be consistent with the induction of CRC1 and
CAT2 whose gene products are involved in β-oxidation
and carnitine-dependent transport of acetyl-CoA from
peroxisomes to mitochondria as a way of using carbon
from sources other than glucose [12]. The induction of
SFC1, JEN1, FBP1 and ATO2 seen in our study has previ-
ously been reported to be a specific identifier of carbon-
limited growth [13].
All TCA- and glyoxylate cycle genes have increased 
expression in V5.TM6*P compared with V5
The genes encoding the enzymes of the TCA cycle (CIT1,
ACO1, IDH1, KGD1, KGD2, LSC2, SDH1-4, FUM1,
MDH1) all have a significant (adjusted p-value < 0.05)
increase in expression when comparing V5 and
V5.TM6*P. In addition, the gene encoding an isoform of
aconitase (ACO2) has its expression level reduced by a fac-
tor of 0.5. Fermentation is almost completely abolished in
the V5.TM6*P strain, and we have previously shown that
the TCA cycle has a higher carbon flux [2] to harness the
electron flow into the respiratory chain and generate a
proton gradient using F0F1-ATPase for ATP synthesis (sev-
eral respiratory chain genes are induced, as discussed
below). Interestingly, all genes of the TCA-cycle are
induced by greater than a factor of 3.5 except for CIT1/
CIT2 and KGD1/KGD2 where the factor change is 2.2 –
3.5 for each gene of the pair, presumably yielding the
same overall transcriptional response. Consistent with
this, Ohlmeier and colleagues have shown that Sdh1, 2
and 4 all have increased expression after a diauxic shift
[6].
The glyoxylate cycle is anabolic, yielding gluconeogenic
precursors, and all its genes (CIT2, ACO1, ICL1 (induced
by a factor of 1.5; Additional file 3), MLS1 and MDH2) are
induced in V5.TM6*P compared with V5 (Additional file
1, Fig. 1). This could be consistent with the correspond-
ingly increased biomass yield of the V5.TM6*P strain
(Table 1). We note that V5.TM6*P has a lower biomass
yield than expected from a totally respiratory phenotype.
In chemostat culture under aerobic, fully respiratory con-
ditions, a yield of 0.5 g/g is typical at low dilution rates,
whereas the observed low yield in V5.TM6*P has alreadyPage 3 of 17
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An overview of our dataset in the context of key yeast metabolic pathwaysFigur  1
An overview of our dataset in the context of key yeast metabolic pathways. Genes with altered expression in 
V5.TM6*P compared with V5 are marked as follows: induced genes are denoted in large, bold font; down-regulated genes are 
crossed out. Genes that were previously found to be altered in studies of respiratory-state yeast [6], but which are not found 
in our dataset are denoted in small, grey text. The chimeric Tm6*p transporter, which comprises the amino-terminal half of 
Hxt1 and the carboxy-terminal half of Hxt7, is responsible for the respiratory phenotype of V5.TM6*P at high glucose concen-
trations and is present in the plasma membrane. The grey boundaries represent the plasma membrane (top) and the mitochon-
drial membrane (left). †Note that ICL(1.5), NDE1 (1.8) and GPD1 (1.8) are induced in our study (see Additional file 3). ‡ LPD1 is 
a component of pyruvate dehydrogenase.
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tions [2]. Furthermore, numerous experiments on
KOY.TM6*P, our original respiratory strain based on
CEN.PK2-1C, [1] have yielded identical results. These
observations are in agreement with our findings in Table
1 of 0.32 g/g in V5.TM6*P and 0.21 g/g in V5 from batch
cultures.
Genes encoding respiratory chain enzymes are induced in 
V5.TM6*P compared with V5
33 key genes encoding mitochondrial enzymes involved
in respiration – as well as F0F1-ATPase and its chaperones
– are all induced by a factor of 2 – 4 in V5.TM6*P (Addi-
tional file 1). The gene encoding Ndi1 (Fig. 2), which
transfers electrons from NADH to ubiquinone (Q in Fig.
2) is induced the most (by a factor of 4.1), while all other
components of the respiratory chain are induced by a fac-
tor of 2 – 2.5. Genes encoding heme synthesis and incor-
poration (HEM2, CYT2), complex assembly (MBA1) and
heme degradation (HMX1) are also induced by a factor of
2 – 2.5. Cytochrome c oxidase also has different chaper-
ones that are induced to form an active structure by prote-
olysis (COX20), as well as delivery of copper (COX17). In
spite of the higher respiratory rate in V5.TM6*P, several
genes involved in detoxification of oxygen radicals are
repressed, e.g. genes encoding peroxiredoxin (AHP1) and
thioredoxin (TRX2) are repressed by a factor of 0.4 – 0.5.
Conversely, the capacity for nitrous oxide detoxification is
increased by the induction of YHB1 by a factor of 2.4. It is
possible that the respiratory phenotype of V5.TM6*P
could induce a higher level of oxygen radical formation
inside its mitochondria and thus oxidation of guanine
could occur on the mitochondrial DNA. Such detrimental
effects could be counteracted, via the observed induction
of OGG1 by a factor of 2.2.
Changes of expression in genes encoding mitochondrial 
and plasma membrane transporters are consistent with a 
respiratory phenotype in V5.TM6*P
The genes encoding the hexose transporters, Hxt1 to Hxt7,
have very high sequence identities [14] and thus cross
reactivity between them is expected on the array. This
explains the observed signal for HXT1, 4 and 6, which
have been deleted in V5.TM6*P. HXT13, HXT15 and
HXT16 are known to be repressed by high levels of glucose
and are consequently induced as expected in V5.TM6*P. A
carbon source deficiency triggers an up-regulation of
genes encoding plasma membrane proteins responsible
for the import of alternative carbon sources, as already
noted: STL1 (21.7; glycerol); JEN1 (10.2; lactate), PUT4
(5.8; proline – the main nitrogen source in grape juice)
and MAL31 (3.1; maltose). A gene associated with nutri-
ent deficiency in yeast [15], YGP1, is induced by a factor
of 2.6, again supporting the notion that V5.TM6*P has
undergone a genetic adjustment compared to its parent.
It seems that V5.TM6*P also has an altered requirement
for metal ions in that genes encoding three metal ion
channels have altered expression: CTR3 (copper trans-
port) is induced by a factor of 3.0, while ZRT1 (zinc trans-
port) and ENB1 (iron transport) are repressed by a factor
of 0.4 – 0.5. It is likely that copper import is increased so
Table 1: Growth characteristics of V5 and V5.TM6*P at 30°C starting at 50 g/L glucose.
V5 V5.TM6*P
Generation time during glucose growth (h) 3.7 (0.2; n = 2) 4.5 (0.3; n = 4)
Biomass yield (g/g) 0.21 (0.02 ; n = 2) 0.32 (0.01; n = 4)
Glucose consumption (mmolg dry weight)-1h-1 9.00 (0.70; n = 2) 2.70 (0.20; n = 4)
Ethanol yield (g/g) 0.33 (0.01; n = 2) 0.05 (0.01; n = 4)
Glycerol yield (g/g) 0.04 (0; n = 2) 0
Yields were calculated as g product (dry weight, ethanol or glucose, respectively)/g of glucose consumed/catabolised for V5 and V5.TM6*P, cultured 
as described in 'Materials and Methods'. The numbers in parentheses are the standard error of the mean, together with the number of replicates (n) 
for each experiment. The seemingly low biomass yield for V5 was measured after consumption of all glucose. Yield increases as all ethanol and 
glycerol are consumed during subsequent respiratory growth.
An overview of our dataset in the context of the respiratory chain in y astFigur 2
An overview of our dataset in the context of the res-
piratory chain in yeast. Genes with altered expression in 
V5.TM6*P compared with V5 are marked as follows: genes 
induced by a factor ≥2.0 are denoted in large, bold font; 
genes induced by a factor <2.0 are denoted in smaller, grey 
font.
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which is the main copper-requiring enzyme in Additional
file 1, with 3 copper ions per complex and a copy number
of 5,000–12,000 per cell. There are only 45 genes in Addi-
tional file 1 with greater than 5,000 copies per cell and
none of these has copper as a prosthetic group except cyto-
chrome c oxidase.
The amino acid uptake systems encoded by BAP3 and
GNP1 are repressed while the proline permease encoded
by PUT4 is induced. PUT4 has a carbon source responsive
element (CSRE) [16] that is expected to be induced at the
low glucose flux experienced in the V5.TM6*P strain,
while BAP3 and GNP1 are regulated by a sensor of extra-
cellular amino acid concentration, where Ssy5 [17] is a
vital component. It is likely that in V5.TM6*P the repres-
sion of BAP3 and GNP1 is a result of the repression (by a
factor 0.65; Additional file 3) of SSY5 seen on the cDNA
array. Interestingly, induction of genes encoding the
ammonia transport system in the V5.TM6*P strain
(ATO2, MEP1) could suggest that the strain is experienc-
ing general nutrient limitation. It has previously been
reported for example that the induction of another MEP
family member, MEP2, is associated with nitrogen limita-
tion [13].
88% of genes induced in V5.TM6*P compared to its parent 
have transcription factor binding sites for one or more of 
the Hap complex, Cat8 or Mig1
Genome-wide studies have yielded a wealth of informa-
tion on which promoters are bound by different transcrip-
tion factors [18]. In order to rationalise these resources,
we began by looking for biologically-verified data on tran-
scription factors that might control the repression of the
subset of 44 genes of Additional file 1. Since only limited
information was publicly available, we did not pursue this
part of the dataset further. In contrast, for the 146 induced
genes in Additional file 1, our observation of the similar-
ity between the transcriptional changes in the V5 to
V5.TM6*P transition and those in the transition from glu-
cose to ethanol growth lead us to analyse the roles of
Hap4, Cat8 and Mig1 which have been previously been
verified to be crucial to the expression of genes in the
diauxic shift [16,19,20]: Hap4 (in complex with Hap2, 3
and 5) [19] and Cat8 (optionally in complex with Sip4
and Adr1) [21] are transcriptional activators, whereas
Mig1 (optionally with Mig2/3) is a transcriptional repres-
sor that works in concert with Tup1-Cyc8 [22].
The Hap complex is comprised of proteins Hap2, 3, 4 and
5, and has separate subunits for DNA binding and tran-
scriptional activation. DNA binding is mediated by Hap2,
3 and 5 [23] while Hap4 functions as an activation
domain. The expression of HAP4 is repressed by glucose
and is responsible for regulation of Hap complex target
genes. We began by scrutinising data for a HAP4 over-
expression strain, in which 246 genes had their expression
affected by at least a factor of 2 [19], which is 5.3% of the
genome. 56 of these genes were found in our dataset and
are listed in Table 2. Only three of these (GLK1, CTR3 and
ZRT1) are down-regulated in the HAP4 over-expression
strain, whereas GLK1 and CTR3 are induced in the
V5.TM6*P strain. Interestingly, a typical Hap complex
binding site was not seen in the 500 nucleotide region
upstream of the GLK1, CTR3 and ZRT1 start codon (where
the first A in ATG is position 1) while all other genes in
Table 2 except AGX1, MNP1 and YNK1 were found to
have at least one Hap complex binding site. These Hap
complex-binding-site-containing genes comprise a signif-
icant subset (26% of our dataset of 190 genes in Addi-
tional file 1) with a verified biological dependence on
Hap4 activation. Clearly, then, Hap4 has a statistically-sig-
nificant role to play in the metabolism of V5.TM6*P as
there is an association between Hap4 dependence and our
dataset (χ2 = 182.75, degrees of freedom = 1, p = 0.00).
Since six of the genes from the HAP4 over-expression
study did not contain Hap complex binding sites, we did
a further in silico analysis of the induced genes of Addi-
tional file 1. We noted that the genes of Table 2, contained
motifs that could be sub-divided into 2 distinct families:
CCAATG (which we denoted as a Hap4_1 site) and (G/
C)CAA(G/T)CAA (a Hap4_2 site). The bold sequences are
the conserved sequences previously identified in the
HAP4 over-expression strain study [19]. The genes of
Additional file 1 were then examined 500 nucleotides
upstream and 200 nucleotides downstream from the start
codon using WebMOTIF [24] for these two biologically-
relevant sites since it has been previously demonstrated
that Hap complex binding sites are statistically over-repre-
sented up to 400 nucleotides upstream from the start
codon [19]: we found that 112/146 (77%) induced genes
and 127/190 (67%) of the complete dataset in Additional
file 1 had one or more Hap complex binding site (Addi-
tional files 1 and 4). Our analysis included presumed
binding sites such as CAAATC and CCAAAC which arose
from the biologically-verified data on transcription factors
(Table 2). For example, AQY2 is identified as Hap com-
plex-dependent, and has two CCAAAC sites, but no
CCAATNA sites. There are only two other genes that do
not contain CCAATNA sites in Table 2, namely CRC1 and
ALD6. In addition it was notable that Hap complex con-
sensus sequences are predominantly found upstream of
mitochondrial genes with 84/127 (66%) of such genes
having at least a partial mitochondrial location. Further-
more, of the induced genes with a known cellular location
and at least two Hap complex binding sites, 69/80 (86%)
are localized to the mitochondria. It appears, then, that
Hap4 activation is preferentially directed at mitochondri-
ally-related functions especially within the TCA-cycle andPage 6 of 17
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HAP4 over-expression.
ORF GENE FACTOR CHANGE IN GENE 
EXPRESSION FROM V5 TO V5.TM6*P
FACTOR CHANGE IN GENE EXPRESSION FROM WT 
TO A HAP4 OVER-EXPRESSION STRAIN [19]
Glycolysis
YCL040W GLK1 3.8 0.4
Alternative carbon source utilization
YML054C CYB2 10.1 5.0
TCA cycle
YIL125W KGD1 2.2 2.2
YDR148C KGD2 3.5 4.4
YFL018C LPD1 2.0 2.2
YKL085W MDH1 3.6 2.2
YKL148C SDH1 4.6 4.7
YLL041C SDH2 4.1 3.9
YKL141W SDH3 3.7 2.3
YDR178W SDH4 5.3 3.2
Glyoxylate cycle
YIR029W DAL2 3.0 3.0
Respiratory chain
YPL078C ATP4 2.1 2.0
YKL016C ATP7 2.3 2.4
YPR020W ATP20 2.5 3.4
YGR174C CBP4 2.8 2.1
YBL045C COR1 2.0 2.0
YGL187C COX4 2.0 2.3
YNL052W COX5A 2.0 2.1
YHR051W COX6 2.1 2.2
YLL009C COX17 2.8 4.7
YOR065W CYT1 2.5 2.3
YKL087C CYT2 2.2 2.8
YIL098C FMC1 2.5 2.3
YDL181W INH1 2.2 5.5
YBR185C MBA1 2.3 2.3
YML120C NDI1 4.1 4.4
YEL024W RIP1 2.3 2.4
YPR151C SUE1 2.2 3.0
Plasma membrane transport
YLL052C AQY2 3.0 3.0
YLR411W CTR3 3.0 0.5
YGL255W ZRT1 0.5 0.1
Mitochondrial transport
YNR002C ATO2 3.8 3.8
YKL217W JEN1 10.3 2.9
YPL134C ODC1 6.3 3.3Page 7 of 17
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cycle is also potentially regulated by Hap4 activation
(Additional file 1). It was further noted that multiple Hap
complex binding sites are associated with induction (Fig.
3A). A Fisher's exact test showed that there was a statisti-
cally-significant association between the change in gene
expression and the number of Hap complex binding sites
in the gene (p = 0.00). This supported the fact that genes
with two or more Hap complex binding sites are likely to
be induced, whereas those with one site may be either
induced or repressed.
In order to adopt a similar approach for Cat8, we exam-
ined available biological data for Cat8 and Adr1 (as they
are co-regulators [25]) from chromatin immunoprecipita-
tions [25], and mRNA expression ratios in wt/Δcat8
strains [16]. We identified 20 genes out of 66 from these
studies that were also in our dataset (Table 3). Only ATO2
Transcriptional regulation
YOL071W EMI5 2.1 2.9
YNL333W SNZ2 3.0 6.4
Fatty acid metabolism
YKL150W MCR1 3.1 2.8
Biosynthesis
YFL030W AGX1 3.6 7.8
Ribosomal proteins in the mitochondria or cytosol
YDR296W MHR1 2.0 2.5
YGL068W MNP1 2.1 2.4
YDR116C MRPL1 2.6 3.5
YKL138C MRPL31 2.2 2.8
YGR165W MRPS35 2.0 2.7
YHR038W RRF1 (FIL1) 2.2 4.8
YDR041W RSM10 2.1 2.4
YDR175C RSM24 2.4 2.9
YFR049W YMR31 2.5 2.6
Other
YBR262C AIM5 2.3 2.1
YFR011C AIM13 2.1 3.4
YLR168C AIM30 2.6 3.3
YML087C AIM33 4.2 11.6
YBR230C OM14 3.3 2.4
YDL104C QRI7 2.1 2.7
YOR187W TUF1 2.3 2.4
YKL067W YNK1 3.1 2.1
Not characterized
YGR110W N/A 2.3 2.0
Genes were tabulated and sorted according to their roles in yeast cellular physiology, as described in the legend for Additional file 1. Note that the 
seven hexose transporter genes, HXT1-7, are deleted in the V5.TM6*P with the amino-terminal half of HXT1 and the carboxy-terminal half of 
HXT7 reincorporated as the TM6* chimera. In the 'Factor Change' column, change is expressed as a factor, where that factor is x when a gene 
expressed with intensity '1' in V5 is expressed with intensity 'x' in V5.TM6*P. All T-tests were jointly adjusted for multiple testing using the false 
discovery rate method (disregarding correlations between genes): p-values were adjusted so that when selecting all genes with p-values less than a 
threshold q, a proportion of q false positives would be expected amongst these genes. The genes shown have p-values < 0.05, and thus the 
expected false discovery rate is 5%. The factor in the final column is taken from Lascaris et al [19]. †Note that due to overall high homology within 
the hexose transporter family, changes were still observed on the cDNA array for HXT4 (YHR092C) even though it is deleted as already 
mentioned.
Table 2: Biologically-verified data on transcription factors that act on genes also found in Additional file 1: transcript dependence on 
HAP4 over-expression. (Continued)Page 8 of 17
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For all other genes, the change in expression followed the
same trend of up-regulation (Table 3). As for the Hap4
analysis, we examined these 20 genes for Cat8 binding
sites, and identified a typical Cat8 motif [21] in 13 of
them, nine being of the Cat8-Sip4 type, TCCATTSRTC-
CGR (Additional file 4). The remaining six induced genes
(CYB2, GUT1, GUT2, LSC2, SUE1 and ODC1) were fur-
ther scrutinised, and it was apparent that all except ODC1
had been identified from immunoprecipitation data for
Adr1 alone, consistent with their lack of Cat8-Sip4 motif.
The induced genes of Additional file 1 were therefore
searched from the start codon to 1,500 nucleotides
upstream for the generic Cat8 motif, CC------CCG motif
giving 54 genes (Additional file 4). The non-coding inter-
genic regions of these genes were then searched using
WebMOTIF [24] and HXK1, COX4, ODC1, OM14, OM45
and YOR019w were found to share the consensus
(A) The influence of multiple Hap complex sites on the change in gene expression of the genes in Additional file 1Figure 3
(A) The influence of multiple Hap complex sites on the change in gene expression of the genes in Additional 
file 1. A Fisher's exact test was performed for genes containing predicted binding sites for the Hap complex and their associa-
tion with induction or repression. Genes were grouped into either those with one Hap complex binding site or those with two 
or more according to Additional file 1. (B) The influence of Hap4, Cat8 and Mig1 on the magnitude of induction of 
the genes in Additional file 1. The average fold-induction of genes in Additional file 1, grouped according to the transcrip-
tion factor binding sites they contain, was calculated. It was observed that those containing binding sites for each of the Hap 
complex (where Hap4 is the activator), Cat8 and Mig1, had the highest average fold induction with Mig1 being a dominant fac-
tor in high induction. A bar for Cat8 is not included as only one gene (YOR019W, factor change 2.1) has a Cat8 site alone. (C) 
A Venn diagram of the distribution of binding sites for the Hap complex, Cat8 and Mig1 in the genes in Addi-
tional file 1. 88% of the genes in Additional file 1 contain a binding site for one or more of the Hap complex, Cat8 and Mig1. 
The range of induction for the 190 genes from Additional file 1 is 2.0 to 21.7.Page 9 of 17
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and are thus also listed in Additional file 4. We noted that
genes with these Cat8 binding sites are induced in
V5.TM6*P by an average factor of 6.2 while the average for
induced genes in Additional file 1 is 3.3. The highly-
induced, Cat8-site-containing genes include HXK1 (factor
change 9.0), PCK1 (6.9), STL1 (21.7), JEN1 (10.3), ODC1
(6.3) and SFC1 (18.3).
We observed that some strongly-induced genes in Addi-
tional file 1 did not have Hap complex or Cat8 binding
sites. Indeed, the expression of many genes such as SUC2
is already known to be repressed by both Mig1 and Mig2
in glucose media, although Mig1 is the main factor in this
response [20,26]. We therefore examined biological data
on gene expression in Δmig1 and Δmig2 strains [20,26]. In
these studies, 11 genes were presented as being Mig
Table 3: Biologically-verified data on transcription factors that act on genes also found in Additional file 1: transcript dependence on 
Cat8 and Adr1.
ORF GENE FACTOR CHANGE IN GENE EXPRES-
SION FROM V5 TO V5.TM6*Pa
FACTOR CHANGE IN GENE EXPRESSION USING DATA
FROM CHROMATIN IMMUNOPRECIPITATION FOR
Cat8b[25], mRNA EXPRESSION RATIOS FOR WT/Δcat8c[16]
AND IMMUNOPRECIPITATION DATA FOR Adr1d [25].
Gluconeogenesis
YLR377C FBP1 5.3 5.0b; MAXc
YKR097W PCK1 6.9 7.7b; 151c
Alternative carbon source utilization
YPL061W ALD6 2.3 5.2b; 8c
YML054C CYB2 10.1 7.4d
YHL032C GUT1 6.2 3.7d
YIL155C GUT2 3.3 4.6d
TCA cycle
YGR244C LSC2 2.9 5.2d
Glyoxylate cycle
YCR005C CIT2 2.2 1.7c
YLR174W IDP2 4 2.9b; 23c
YOL126C MDH2 3 12.7b; 3.6c
YNL117W MLS1 3.5 8.9b; 79c
Respiratory chain
YPR151C SUE1 3.7 4.4d
Plasma membrane transport
YOR348C PUT4 5.8 2.7b; 6.1c; 2.0d
YDR536W STL1 21.7 4.4c
Mitochondrial transport
YNR002C ATO2 3.8 0.33c
YML042W CAT2 2.6 2.8b; 2.4c
YOR100C CRC1 2.2 8.1c
YKL217W JEN1 10.3 3.6b; 10c; 10.5d
YPL134C ODC1 6.3 3.2b
YJR095W SFC1 18.3 6.2b; MAXc
The table is arranged as for Table 2. Factor changes denoted 'a' are from Additional file 1, 'b' refer to chromatin immunoprecipitation data for Cat8 
[25], 'c' refer to mRNA expression ratios for wt/Δcat8 [16] and 'd' refer to chromatin immunoprecipitation data for Adr1 [25].Page 10 of 17
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(HXK1, EMI2, HXT13, HXT15 and DSF1) and 3 in Addi-
tional file 3 (REG2, DOG2 and YLR042C). We then exam-
ined protein binding microarray data [27] and tabulated
the combined outputs as Table 4, which lists 15 Mig-
dependent genes. When searching the induced set in
Additional file 1 in silico for genes containing Mig1 bind-
ing sites, 31 were identified, predominantly containing
consensus sequences of the SUC2B type (CCCCGGAT),
but also in some cases sites that were more homologous
to SUC2A (sharing the consensus motif CCCC(G/A)(G/
C)AT [28]). We noted that the presence of a Mig1 site in a
gene correlated with high induction (Fig. 3B) and that
overall, our analysis provides a highly complete descrip-
tion of how three transcriptions factors might regulate the
146 induced genes of Additional file 1 (Fig. 3C).
We noted that HAP4 (factor change 1.7, Additional file 3)
is induced and CAT8 (0.5, adjusted p value < 0.06; Addi-
tional file 5), MIG2 (0.5, Additional file 1) and MIG3 (0.3,
Additional file 1) are down-regulated in V5.TM6*P com-
pared to V5. In our dataset, the specific change in array sig-
Table 4: Biologically-verified data on transcription factors that act on genes also found in Additional file 1: transcript dependence on 
Mig1.
ORF GENE FACTOR CHANGE IN GENE
EXPRESSION FROM V5 TO V5.TM6*Pa
Mig1 BINDING VERIFIED USING DATA FROM PROTEIN-
BINDING MICROARRAYb [27] AND IN VIVOc [26] ANALYSES
Glycolysis
YFR053C HXK1 9 b,c
Gluconeogenesis
YLR377C FBP1 5.3 b
Alternative carbon source utilization
YHL032C GUT1 6.2 b
YIL162W SUC2 6.8 c
Glyoxylate cycle
YCR005C CIT2 2.2 b
Plasma membrane transport
YEL069C HXT13 3.9 b,c
YDL245C HXT15 3.2 c
YBR298C MAL31 3.1 b
Mitochondrial transport
YNR002C ATO2 3.8 b
YKL217W JEN1 10.3 b
YPL134C ODC1 6.3 b
Transcriptional regulation
YDR516C EMI2 3.6 b,c
YEL066W HPA3 2.2 b
Other
YEL070W DSF1 9.4 b,c
YGR243W FMP43 4.9 b
The table is arranged as for Table 2. Factor changes denoted 'a' are from Additional file 1. Mig1 binding was verified using data from protein-binding 
microarray [27] studies denoted 'b' and in vivo [26] analyses denoted 'c' although no factor changes were indicated in those studies.Page 11 of 17
(page number not for citation purposes)
BMC Genomics 2008, 9:365 http://www.biomedcentral.com/1471-2164/9/365nal for MIG1 had an adjusted p-value > 0.05 over the
complete experimental range. The result for CAT8 was
unexpected as it contains an upstream Mig1 binding site
similar to HAP4 (which is induced) and Cat8 target genes
such as FBP1 and PCK1 are themselves induced. It is pos-
sible that the transcript was not probed accurately on the
array either due to cross-hybridisation between closely
related DNA sequences or on account of its low base
expression value (0.24). A future real time Q-PCR experi-
ment would probe the individual transcript.
Transcripts dependent on external glucose concentration 
are not found in the respiratory V5.TM6*P strain, even 
though several glucose- or carbon-source-associated 
transcripts are glucose dependent in the parental wild-
type strain
The transcriptome of the respiratory V5.TM6*P strain was
not found to be responsive to changes in glucose concen-
tration in the culture medium. However, in the wild-type
parent strain (V5) the transcriptome was found to vary
with glucose availability according to a least squares fit of
the logarithmic array values for RNA extracted at the six
different glucose concentrations. This dependence on
external glucose concentrations is seen in the V5 strain for
20 genes (including those without functional annota-
tions) with an adjusted p-value < 0.05 (Fig. 4). The genes
with the strongest dependence on external glucose con-
centrations were found to be HXK1, RGS2, ADH7, CHA4
and GLK1 (Fig. 4). The sugar kinases HXK1 and GLK1 are
induced as expected as they have their maximal expres-
sion during growth on other carbon sources [16]. The
gene product of RGS2 inhibits Gpa2 in the PKA pathway,
which is one of the pathways induced by glucose [29].
ADH7 appears to be induced on carbon sources other
than glucose [30]. In a study by DeRisi and colleagues,
batch yeast cultures were harvested for cDNA array analy-
sis at gradually decreasing glucose concentration [5]. Our
examination of the supplementary data provided by the
authors showed that as glucose was consumed between
18.7 and 7.5 g/L, three of the genes in Figure 4 (GLK1,
HXK1, and FAL1) were found in the top 22 genes with a
changed expression from that study. Overall, the results in
Figure 4 show that glucose repression is gradually relieved
on going from 37 g/L to 9 g/L glucose. Furthermore relief
of repression is already apparent at a surprisingly high glu-
cose concentration, in contrast to the assumption that it is
typically triggered over a range of low glucose concentra-
tions [29], the trigger being very low for some genes [31].
Transcript dependence on external glucose concentration for 20 genes in the V5 strainFigure 4
Transcript dependence on external glucose concentration for 20 genes in the V5 strain. A clear glucose-depend-
ence (grey bars) was observed for all genes in the V5 strain with only a small variation in array signal (white bars) for the same 
genes in V5.TM6*P. Genes marked with a dot also have a significant change of expression on going from V5 to V5.TM6*P and 
as such are listed in Additional file 1. The factor change in gene expression was obtained as the quotient between the expres-
sion values at 37 and 9 g/L glucose given by the line fitted to the expression data for each gene. R2 values are for the linear fit 
for the V5 strain. The R2 values for V5.TM6*P were between 0.16 and 0.78 indicating no significant linear relationship.Page 12 of 17
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genes in V5 affected our data in Additional file 1, we
excluded the data points at 13.5 and 5.6 g/L glucose for
V5.TM6*P, and 10.5 and 7.4 g/L glucose for V5 (which
gave the highest array signals) and compared the cDNA
array data in this case with each other exactly as for the full
data set. Following this procedure, only a small subset of
genes that are highly induced had their factor changes
increased substantially, but this did not affect the fact that
they remain within the top 30 most induced genes in
Additional file 1. They are HXK1 (9.0 in Additional file 1,
19.3 following re-calculation; the gene contains binding
sites for the Hap complex, Cat8 and Mig1); STL1 (21.7,
27.5; Hap complex, Cat8); DSF1 (9.4, 15.1; Hap complex,
Mig1); CYB2 (10.1, 13.4; Hap complex, Mig1) and FBP1
(5.3, 7.4; Cat8, Mig1). Fourteen of the seventeen genes
that were most affected by this recalculation were found to
contain a Mig1 binding site. It is therefore possible that
Mig1 is also involved in relieving glucose repression in the
10 to 5 g/L range, and not only at the depletion of glucose
at the diauxic shift. Overall, we found that the amplitudes
of the factor changes varied by only 9.3% in this new cal-
culation compared with the original one, which indicated
that the glucose dependence of the V5 strain does not
have a major influence on the way we generated the data
presented in Additional file 1.
Discussion
The main physiological change in both the diauxic shift
and the transition from a respiro-fermentative to a respi-
ratory metabolism is that glycolysis is channelled to sup-
port respiration: this occurs upon glucose depletion
during the diauxic shift and throughout the growth curve
in glucose medium in V5.TM6*P. Although previously-
published genomic analyses of yeast's response to the
diauxic shift transition have all been sampled under dif-
ferent conditions – rich (YPD) medium with 2% glucose
[5], minimal defined medium in chemostat cultures at
different dilution rates [4], and minimal defined media in
batch cultures sampled 4 h after the diauxic shift [3] –
common themes emerge with changes on going from V5
to V5.TM6*P. Overall 81% of genes which are induced or
repressed on going from V5 to V5.TM6*P in our study
were found in at least one of these three datasets for the
diauxic shift. Furthermore, we also find that for all pro-
teins induced in a study of the diauxic shift by 2D-gel elec-
trophoresis [6], the corresponding genes are induced on
going from V5 to V5.TM6*P except for the alcohol dehy-
drogenase, Adh2. There is a hence close agreement
between induction of the following genes and the levels of
the corresponding proteins: FBP1, ICL1, PCK1, IDP2,
MLS1, DLD1, ALD6, SDH1 and CIT2. This strong correla-
tion with previously-published data and our own
observed correlation of data for Cdc19 and CDC19 sup-
ports the phenotypic similarity between the V5 to
V5.TM6*P transition and the diauxic shift. It is worth not-
ing that there is no clear correlation of our data in Addi-
tional file 1 with any possible differences in growth rate
between the two strains. In a study by Regenberg and col-
leagues [32], 180 genes changed in expression by more
than a factor of 4 when comparing growth rates. Of these
180, 3% of all genes are found in Additional file 1 provid-
ing no significant overlap in data.
It is also possible to see parallels between our data set and
a study of nitrogen deprivation and stationary phase
growth for wild-type yeast by Gasch and colleagues [33].
This is supported by the fact that ten of the 15 genes that
were found to be strongly induced upon nitrogen depriva-
tion and growth in stationary phase in that study are also
induced in the V5 to V5.TM6*P transition. Only two
genes, YGR067c (likely to encode a transcription factor as
it has high partial sequence homology with MIG3 and
ADR1 and it fine-tunes the response to nutrient limita-
tion) and ECM13, are not induced in the V5.TM6*P
strain, but were highly induced in the Gasch study [33]
upon nitrogen deprivation and stationary phase growth.
In addition, we find that the genes encoding Mep1 and
Ato2, which are involved in ammonia transport are also
strongly induced in V5.TM6*P in our study. Such an
induction is seen in both the diauxic shift studies per-
formed in defined media [4,34], but not in rich medium
[5], suggestive of nutrient limitation. In fact, V5.TM6*P
also appears carbon limited, not least as a result of the fact
that amongst the most strongly induced genes are FBP1
and PCK1, which encode gluconeogenic enzymes. STL1,
MAL31 and SUC2 (encoding proteins involved in usage
and/or transport of alternative carbon sources: glycerol,
maltose and sucrose respectively) are induced in
V5.TM6*P, also consistent with its low glycolytic flux and
suggestive of an adaptation of metabolism ('discontinu-
ous modelling) as seen by Brauer and colleagues [4,34]
and supported by our previous work [1]. Several of these
genes including FBP1 and STL1, as well as JEN1, ODC1,
SFC1 and ATO2 have already been identified as being
either induced under carbon limitation or being specific
indicators of carbon limitation in yeast cultures [13], con-
sistent with our own data.
The analysis of transcription factor binding sites present
in the genes of Additional file 1 revealed that 127 genes
had Hap complex binding sites, the majority of which
encode mitochondrial proteins. Of genes that only had
Hap complex binding sites present, thirteen had only one
and of these only five were induced leading us to hypoth-
esise that multiple Hap complex binding sites are corre-
lated with induction of the Additional file 1 genes (Fig.
3A). Interestingly, in a microarray screen of a hap1Δ
mutant for Hap1-dependent genes [35], 7/24 genes that
were induced in the hap1Δ mutant are also induced inPage 13 of 17
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PUT1), and in each case also have a Hap complex binding
site. In addition, 19 genes containing a Cat8 site and 31
genes containing a Mig1 site were predicted, with many of
these genes being experimentally-verified in previous in
vivo studies. Our analysis of the regulation of 88% of the
induced genes of our unique respiratory strain (Fig. 3) is
further supported by a novel computational method [36]
that predicts the Hap complex and Mig1 control the genes
of Additional file 1; Cat8 is not included in that database.
A quite unexpected result from comparing the transcrip-
tional profiles of V5 with V5.TM6*P is the data set in Fig-
ure 4, showing genes from the parent strain that are clearly
glucose dependent and that the glucose dependence
observed begins at concentrations (6 – 36 g/L glucose)
higher than the range generally regarded as the glucose-
repressed region. Strain DBY7286 [5], which is unrelated
to V5, previously showed a gradual relief of glucose
repression starting at 20 g/L glucose for GLK1, HXK1 and
FAL1. These results for V5 and DBY7286 suggest that grad-
ual relief is a general S. cerevisiae phenomenon. Future
studies will show whether the gradient of the slope is dif-
ferent for different strains. That such glucose dependence
requires an intact glucose uptake system is suggested by
the fact that it is not seen in the V5.TM6*P strain: the array
signal is not changed significantly for any of the genes in
the V5.TM6*P strain at the different glucose concentra-
tions sampled. This implies that in V5.TM6*P, glucose
sensing is independent of external glucose concentration.
The wild-type yeast, on the other hand, shows an exten-
sive modulation of its expression profile at high glucose
concentrations despite the fact that its physiological
response is largely unaffected. The insensitivity of the
V5.TM6*P strain therefore makes it an extremely valuable
biotechnological tool as it can be cultured in a wide range
of external glucose concentrations, whilst maintaining the
same respiratory phenotype [2].
Conclusion
In this study, we have been able to characterize the tran-
scriptome of a unique respiratory yeast strain. We have
been able to identify highly complete collections of
known genes in the TCA cycle, glyoxylate cycle and respi-
ratory chain that are consistent with a respiratory metabo-
lism. Our results suggest that there has been genetic
remodelling predominantly through the activity of Hap4,
Cat8 and Mig1, and that the gene expression profile of
V5.TM6*P during growth on glucose resembles wild-type
S. cerevisiae cells in the diauxic shift.
Methods
Yeast strains
The auxotrophic wine yeast strain V5 (MATa ura3 gal) and
the V5 hxt1–hxt7Δ mutant strain (MATa ura3 gal
hxt514Δ::loxP hxt367Δ::lox P hxt2Δ::loxP) were kindly
provided by the Professor Bruno Blondin, Montpellier,
France. The construction of V5.TM6*P was previously
described by Henricsson and colleagues [2] where the
expression cassette from KOY.TM6*P [1] was transferred
into the genome of the V5 hxt1–hxt7Δ strain by using the
primers PROHXT3 (TCAAATGGCGGTGTAGTTT-
GAAAAG) and TERHXT7 (TTAAGTGACGGGCGATGAG-
TAAGAA). Transformants were selected by growth on
glucose. The resulting ura3 strain is referred to as
V5.TM6*. The auxotrophic V5 wild type and V5.TM6*
used in this study were made prototrophic by integration
of URA3 [37] and are referred to as the V5 wild-type strain
and V5.TM6*P, respectively.
Growth conditions
For both pre-cultures and main cultures, 5 × defined min-
imal medium [38] with 5% glucose as the sole carbon and
energy source was used. A two-step pre-cultivation was
performed on a rotary shaker. First a 10 mL culture was
grown for 72 h, and used to inoculate 100 mL medium,
which after 30 h at 30°C was inoculated to give a final
OD610 of 0.05 in a bioreactor (BRO2, Belach Bioteknik
AB, Sweden) in a volume of 2.5 L. Polypropylene glycol
P2000 was added as antifoam (100 μL/L). The cultivation
conditions were 30°C, 1,000 rpm, pH 5.0 with an airflow
of 1.25 L/min. Gas evolution was monitored on-line (type
CP460 O2/CO2, Belach Bioteknik AB). Cultivations were
performed at least in duplicate.
RNA preparation
Yeast cells (2 – 20 mL) were directly transferred into twice
their volume of ice-cold water. The cells were collected by
centrifugation at 0°C for 5 min at 3000 × g, frozen in liq-
uid nitrogen and stored at -80°C. Total RNA was then pre-
pared using the RNeasy kit from Qiagen, following the
manufacturer's instructions.
cDNA array production
PCR products for the yeast ORFs were generated from
yeast DNA using the ORF-specific primer set from
Research Genetics and then re-amplified with the Resgen
universal forward and reverse primers (Catalogue number
40612). PCR products were prepared by Randy Strich (Fox
Chase Cancer Centre, USA) as part of a collaboration with
the Wistar Institute, Philadelphia, USA. PCR products
were spotted with a BioRobotics Microgrid TASII
(Genomic Solutions) by the Wistar Genomics Facility.
Each array contained 6,319 individual yeast genes and
1,169 gene repeats. The complete list of arrayed genes on
array YA04 is listed under GEO Series accession number
GPL4423.
RNA amplification, hybridization, and scanning
Amplified RNA (aRNA) was prepared from 1 μg of total
RNA for each sample tested using the RiboAmp kit (Arctu-
rus). Labelled targets were prepared from 1.6 μg aRNAPage 14 of 17
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the presence of 3,000–5,000 Ci/mM [α-33P] dCTP (Amer-
sham Pharmacia Biotech), 1 mmol/L dATP, 1 mmol/L
dTTP, 1 mmol/L dGTP, 67 ng/μg oligo-dT (Promega Bio-
sciences), and 0.65 × random decamer primers (Ambion).
Labelled targets were hybridized to individual arrays at
42°C for 18 h in 3 mL Microhyb buffer (Invitrogen).
Arrays were washed twice in 2 × standard saline citrate
(SSC)/1% SDS solution for 30 min at 50°C, once in 0.5 ×
SSC/1% SDS and once in 0.1 × SSC/0.5% SDS for 30 min
at 55°C. The arrays were exposed to phosphor screens
(Amersham Biosciences) for 6 days and scanned in a
Storm 820 PhosphorImager (Molecular Dynamics).
Quantitation of each spot was assessed by Imagene 5.0
software (BioDiscovery Incorporated) using manual spot
alignment, measuring median pixel intensity for each spot
and subtracting the local background. The data have been
deposited in the NCBI Gene Expression Omnibus and are
accessible through GEO Series accession number
GSE11799.
cDNA array data analysis
Observed values less than 0.1 (5% (8752 values) of the
176640 raw data values) were set to 0.1, in accordance
with information from Wistar that variations in values
below this threshold should be regarded as measurement
noise. After converting to a logarithmic scale, average
expression values were computed over spots with the
same ORF, and arrays were scale normalized by subtract-
ing the median for each of the 24 arrays. Averages were
computed over repeated measurements with the same
conditions producing 6 values at different glucose concen-
trations for each of the V5 (38.4, 35, 25.5, 24.4, 10.5, 7.4
g/L glucose) and V5.TM6*P (36.5, 34.8, 26.3, 25.1, 13.5,
5.6 g/L glucose) strains for each gene. T-tests were then
performed, comparing the two strains, using Empirical
Bayes robustification of variance estimates [39,40].
The T-tests were adjusted for multiple testing using the
false discovery rate method (disregarding correlations
between genes). Essentially, then, p-values were adjusted
so that when selecting all genes with p-values less than a
threshold q, a proportion of q false positives would be
expected amongst these genes. The estimated effects are
shown as factors in Additional file 1, as the linear model-
ling was performed on a log scale. The p-values in Addi-
tional file 1 are the adjusted values, so that selecting genes
with p-values < 0.05 gives an expected false discovery rate
of 5%. Calculations were performed using the BioCon-
ductor package limma [40]. To present the data, a tabular
format was chosen over heatmaps in an attempt to make
it as accessible as possible to the scientific community.
When producing data for Figure 4, a similar linear model
was used, but with a different design matrix: Essentially,
for each gene, 2 straight lines were simultaneously fitted,
one for each of the strains, to plots of the 6 log-expression
values versus glucose concentration. Empirical Bayes
robustification and adjustment for multiple testing was
included even in this analysis, using the limma tool [40].
Lines with slopes significantly different from zero were
found for 20 genes for the V5 strain, but for no genes from
the V5.TM6*P strain.
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Additional material
Additional file 1
Transcriptome analysis of V5.TM6*P compared with the parental V5 
strain. Genes were tabulated if their expression was changed on going 
from the V5 parental strain to V5.TM6*P, as described in 'Materials and 
Methods'. All genes were then sorted according to their roles in yeast cel-
lular physiology and alphabetically by gene name under each sub-heading. 
Note that HXT1-7 are deleted in the V5.TM6*P with a part of HXT1 and 
HXT7 reincorporated as the TM6* chimera. Due to overall high homology 
within the hexose transporter family we still observed changes on the 
cDNA array (HXT1 (YHR094C); factor 0.4; HXT4 (YHR092C); 0.2; 
HXT6 (YDR343C); 2.1; these are not listed in Additional file 2). As 
YLL053C is annotated as continuous with YLL052C (AQY2) in some 
strains, these ORFs are counted once here as YLL052C. Genes that were 
dubious were not included in Additional file 1 and neither were the Ty-
transposable elements, YGR161C-C (encoding TyA gag protein) and 
YNL054W-B (encoding TyB gag protein). The top 30 genes with the larg-
est numerical factor change (both up- and down-regulated) are under-
lined. If no functional information was available, phenotypic data from a 
deletion mutant was entered under 'Function'. In the 'Factor Change' col-
umn, change is expressed as a factor, where that factor is x when a gene 
expressed with intensity '1' in V5 is expressed with intensity 'x' in 
V5.TM6*P. All T-tests were jointly adjusted for multiple testing using the 
false discovery rate method (disregarding correlations between genes): p-
values were adjusted so that when selecting all genes with p-values less 
than a threshold q, a proportion of q false positives would be expected 
amongst these genes. The genes shown have p-values < 0.05, and thus the 
expected false discovery rate is 5%. Transcription factors are listed if a 
binding site was predicted as described in the text. Data on 'Copies/cell' 
are from the yeast GFP fusion localization database and were collected 
from wild-type yeast grown on glucose. 'Protein Localisation' was 
extracted from the Saccharomyces Genome Database on 14th February 
2008 and in each case has been manually curated by the site's curators 
unless the entry is underlined, indicating that the localization has been 
extracted from a genome wide study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-365-S1.pdf]Page 15 of 17
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